Pfizer to present data on ADCs at AACR 2012

[News]

Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizer's early-stage compounds, including data from Pfizer's investigational antibody-drug conjugate (ADC) portfolio and research evaluating several molecules targeting novel pathways that play a crucial role in basic cellular functions, at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, IL, from March 31-April 4.

More... (http://www.news-medical.net/news/20120327/Pfizer-to-present-data-on-ADCs-at-AACR-2012.aspx)